HebeCell, Logomix partner on next-gen genomically engineered PSC-NK cells
As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Aug 23
As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…
11 Aug 23
Under the agreement, Antengene will retain its responsibilities for R&D, regulatory approvals and affairs, product supply, and distribution…
10 Aug 23
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…
10 Aug 23
The proposed acquisition will enhance the ongoing partnership between Decibel and Regeneron and the partnership aims to expedite…
09 Aug 23
Neopharm will be appointed as Amarin’s sole and exclusive distributor to import, register, distribute, and commercialise Vazkepa in…
08 Aug 23
BioNTech will obtain rights to commercialise the DB-1305 worldwide, except in Mainland China, Hong Kong Special Administrative Region…
08 Aug 23
According to the terms of the agreement, Astellas will invest $25m to buy 8,333,333 shares of common stock…
04 Aug 23
In exchange for the exclusive global right to the TMPRSS6 siRNA programme, Alnylam will receive a $17.5m upfront…
04 Aug 23
The expanded agreement includes the renewal of the non-exclusive total laboratory solution collaboration agreement and an eco-social collaboration…
03 Aug 23
The three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies, including…